Press Releases

Researchers Show That a Machine Learning Model Can Improve Mortality Risk Prediction for Cardiac Surgery Patients
May 17, 2023 - A machine learning-based model that enables medical institutions to predict the mortality risk for individual cardiac surgery patients has been developed by a Mount Sinai research team, providing a significant performance advantage over current population-derived models.

Mount Sinai researchers discover novel receptors for SARS-CoV-2 and their age-dependent expression, providing new insights for public health
April 11, 2023 - A study led by Mount Sinai researchers has identified potential novel receptors for SARS-CoV-2 and unveiled their tissue-specific and age-dependent expression.

Genetic Causes of Three Previously Unexplained Rare Diseases Identified
March 16, 2023 - Using a new computational approach they developed to analyze large genetic datasets from rare disease cohorts, researchers at the Icahn School of Medicine at Mount Sinai and colleagues have discovered previously unknown genetic causes of three rare conditions: primary lymphedema (characterized by tissue swelling), thoracic aortic aneurysm disease, and congenital deafness.

Mount Sinai researchers discover key role of DNA methylation in Alzheimer's disease
February 22, 2023 - Mount Sinai researchers shed new light on the role of DNA methylation in Alzheimer's disease (AD). 

Mount Sinai researchers discover novel mechanism for MRSA virulence
January 23, 2023 - Researchers at Mount Sinai, in collaboration with researchers at New York University. shed light on the mechanisms behind the severity, or virulence, of methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections.

Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai
December 20, 2022 - Using machine learning and clinical data from electronic health records, researchers at the Icahn School of Medicine at Mount Sinai in New York constructed an in silico, or computer-derived, marker for coronary artery disease (CAD) to better measure clinically important characterizations of the disease.

Sites in the Brain Where RNA Is Edited Could Help to Better Understand Neurodevelopment and Disease
November 1, 2022 - Mount Sinai researchers have catalogued thousands of sites in the brain where RNA is modified throughout the human lifespan in a process known as adenosine-to-inosine (A-to-I) editing, offering important new avenues for understanding the cellular and molecular mechanisms of brain development and how they factor into both health and disease.

Targeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studies
October 25, 2022 - A new approach to cancer immunotherapy that uses one type of immune cell to kill another—rather than directly attacking the cancer—provokes a robust anti-tumor immune response that shrinks ovarian, lung, and pancreatic tumors in preclinical disease models, according to researchers at the Icahn School of Medicine at Mount Sinai in New York. 

Researchers Identify Flu-Fighting Pathways and Genes Essential for Influenza A Immune Defense
October 5, 2022 - Researchers have identified the gene TDRD7 as a key regulator against influenza A virus (IAV), which causes respiratory tract infections in 5 to 20 percent of the human population. These findings could facilitate the development of novel therapeutic interventions against influenza virus infection.

Mount Sinai Launches Large-Scale Genetic Sequencing Project with the Regeneron Genetics Center
August 12, 2022 - Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing research project called the Mount Sinai Million Health Discoveries Program with the Regeneron Genetics Center (RGC), part of the industry-leading, New York-based biotechnology company Regeneron.

Mount Sinai Awarded Three-Year Grant to Explore Therapeutic Approaches to KRAS Mutant Lung Tumors
August 9, 2022 - Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 grant from Stand Up To Cancer® (SU2C) to explore therapeutic approaches to lung tumors with mutations in the KRAS gene, an undertaking that could have a significant impact for a large population of cancer patients who currently lack effective treatment options.

Researchers Gain Insights Into the Genetic and Molecular Machinery that Predisposes Individuals to Alzheimer’s Disease
August 5, 2022 - Mount Sinai researchers have achieved an unprecedented understanding of the genetic and molecular machinery in human microglia—immune cells that reside in the brain—that could provide valuable insights into how they contribute to the development and progression of Alzheimer’s disease (AD).

Mount Sinai Designated as National Cancer Institute Proteogenomics Data Analysis Center
July 14, 2022 - The Office of Cancer Clinical Proteomics Research at the National Cancer Institute (NCI) has awarded $4.2 million over five years to Mount Sinai researchers establishing a Proteogenomic Data Analysis Center (PGDAC) to advance cancer research and treatments. Proteogenomics, which studies the roles of proteins and genes within a cell or organism, is a crucial area of exploration to further our understanding of cancer.

Mount Sinai Microbiome Lab Joins NIH’s Accelerating Medicines Partnership
May 19, 2022 - In this newly funded study, Dr. Jose Clemente and team will try to reconstruct and analyze how the microbiome may work in several autoimmune disorders, including rheumatoid arthritis, systemic lupus erythematosus, psoriasis, psoriatic arthritis, and Sjögren’s disease.

Scientific Consortium Established by National Institutes of Health Provides Real-Time Risk Assessment of SARS-CoV-2 Variants on Immune Protection
March 31, 2022 - Program employs a coordinated approach and serves as a template for response against rapidly evolving pandemic pathogens

Novel CRISPR Imaging Technology Reveals Genes Controlling Tumor Immunity
March 15, 2022 - Next-generation spatial genomics technology paves the way for accelerating the discovery of new cancer drug targets

Are Scientists Being Fooled by Bacteria?
February 3, 2022 - Previous studies of a genetic on/off switch may have been confounded by contamination, but Mount Sinai scientists have created a new tool for accurately determining whether it plays a role in human disease.

Most “Pathogenic” Genetic Variants Have a Low Risk of Causing Disease
January 25, 2022 - Results of large biobank study by Mount Sinai researchers may help doctors better assess true disease risk.

Could Gene Networks Resembling Air Traffic Explain Arteriosclerosis?
January 12, 2022 - Mount Sinai-led study suggests that nearly 60 percent of the risk associated with coronary artery disease may be explained by the activity of multi-organ, gene networks orchestrated by fat processing hormones

Can a Human Microglial Atlas Guide Brain Disorder Research?
January 6, 2022 - Mount Sinai-led study supports links between the brain’s immune cells and some cases of Alzheimer’s or Parkinson’s disease

Mount Sinai Alzheimer’s Researcher Wins Rainwater Prize for Outstanding Innovation in Neurodegenerative Research
December 14, 2021 - The Rainwater Charitable Foundation has named Alison M. Goate, DPhil, the Jean C. and James W. Crystal Professor and Chair of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, as this year’s winner of the Rainwater Prize for Outstanding Innovation in Neurodegenerative Research. The prize recognizes Dr. Goate’s “significant contribution to our understanding of tau-related diseases,” such as Alzheimer’s disease and frontotemporal dementia.

Scientists Show How Bone-Bordering Cells May Help Shape a Skull
December 9, 2021 - Mount Sinai study of mice searched for the cells and genes that may orchestrate how skull bones are joined together

National Organization for Rare Disorders Designates The Mount Sinai Hospital as a Center of Excellence
November 4, 2021 - The National Organization for Rare Disorders (NORD) has designated the Division of Medical Genetics and Genomics at The Mount Sinai Hospital as a Rare Disease Center of Excellence. With this designation, Mount Sinai will join a highly selective nationwide network of 31 medical centers that specialize in rare disease diagnosis, treatment, and research

Childhood Asthma Study Uncovers Risky Air Pollutant Mixtures
October 6, 2021 - Mount Sinai researchers use a novel machine learning algorithm to discover that early exposure to a variety of toxic air pollutants can lead to poor asthma outcomes

Schizophrenia Study Suggests Advanced Genetic Scorecard Cannot Predict a Patient’s Fate
September 7, 2021 - Mount Sinai study showed that polygenic risk scores were no better at predicting whether a patient’s symptoms worsened than written reports

Mount Sinai Researchers Find Important Clue to Rare Inflammatory Disease in Children Following COVID-19 Infection
August 12, 2021 - Mount Sinai researchers have found an important clue to a rare but serious aftereffect of COVID-19 in children, known as multisystem inflammatory syndrome in children or MIS-C.

Genetic Ancestry Versus Race Can Provide Specific, Targeted Insights to Predict and Treat Many Diseases
April 14, 2021 - Complex patterns of genetic ancestry uncovered from genomic data in health care systems can provide valuable insights into both genetic and environmental factors underlying many common and rare diseases

Mount Sinai Study Reveals Genetic and Cellular Mechanisms of Crohn’s Disease
March 31, 2021 - New study identifies a novel approach for tailored treatment that could be more effective for patients with the chronic disease

Mount Sinai Researchers Identify and Characterize Three Molecular Subtypes of Alzheimer’s Disease
January 6, 2021 - Critical Step Toward Developing Precision Medicine Treatments

Multi-Population Risk Scores Could Improve Risk Prediction for Inflammatory Bowel Diseases, Study Finds
December 24, 2020 - New study illustrates how studying diverse populations can help predict patient outcomes and reduce health disparities

First large-scale, multicenter proteogenomic analysis offers new insights into pediatric brain tumor biology
November 25, 2020 - Data reported can guide new therapeutic avenues for pediatric patients

Potential New Therapies for Alzheimer’s Disease are Revealed through Network Modeling of Its Complex Molecular Interactions
November 24, 2020 - Researchers from Mount Sinai and the National Center for Geriatrics and Gerontology in Japan have identified new molecular mechanisms driving late-onset Alzheimer’s Disease (LOAD), as well as a promising therapeutic candidate for treatment

Alison M. Goate Named Chair of Genetics and Genomic Sciences at Icahn School of Medicine at Mount Sinai
November 19, 2020 - Noted Alzheimer’s researcher will assume new role on January 1, 2021

Mount Sinai Receives Microsoft AI for Health Grant to Support Center Dedicated to Data Science Discovery for COVID-19
June 8, 2020 - Grant Will Enable Development of AI Tools to Enhance Care and Evidence-based Medicine for Treating COVID-19 Patients

Mount Sinai Study Finds First Cases of COVID-19 in New York City are Primarily from European and US Sources
June 2, 2020 - First definitive molecular epidemiology study of SARS-CoV-2 in New York City to describe the route by which the virus arrived

Mount Sinai Researchers: Why COVID-19 May Be Less Common in Children Than Adults
May 5, 2020 - Findings Published in JAMA Could Lead to Potential Biomarker of Susceptibility

Mount Sinai Launches App and First Campaign of The Resilience Project to Develop New Treatments and Preventive Care for Diseases
April 13, 2020 - Lyme Campaign Seeks Participants Who Are ‘Resilient’ to the Tick-borne Disease

Mount Sinai Launches COVID-19 App to Track Spread of Virus Across New York City
April 1, 2020 - A team of data scientists, physicians, and engineers across the Mount Sinai Health System has come together to launch STOP COVID NYC, a web-based app to capture the symptoms and spread of COVID-19 in New York City

Airway Microbiome and Host Interact Differently in Children with Severe Asthma
March 12, 2020 - The Mount Sinai study showed that airway microbes interact with inflammatory genes differently in healthy versus asthmatic children.

Researchers Identify Opportunities to Advance Genomic Medicine
January 27, 2020 - New Study Highlights Milestones in the History of Genetic Discoveries; Equitable and Fair Access Required to Address Disparities

Researchers Show Different Mutations in a Single Gene Can Wreak Many Types of Havoc in Brain Cells
December 19, 2019 - NRXN1 undergoes extensive alternative splicing, and non-recurrent heterozygous deletions in NRXN1 are strongly associated with neuropsychiatric disorders. The study published in Nature Genetics reported links to patient-specific, heterozygous intragenic deletions in NRXN1 to isoform dysregulation and impaired neuronal maturation and activity in a human and disease-relevant context.

Multi-omics Approach Offers New Insights into Peanut Allergy Severity
December 12, 2019 - Researchers at the Icahn School of Medicine at Mount Sinai have identified novel genes associated with the severity of peanut allergy, as well as ways in which these genes interact with other genes during allergic reactions. The findings, published in the Journal of Allergy and Clinical Immunology, could lead to better treatments for peanut allergy. 

Genetic Breakthrough Identifies Heart Failure Risk in African and Latino Americans
December 10, 2019 - A genetic variation believed to increase risk for heart failure in people of African or Latino ancestry has been identified in a new study by researchers from the Icahn School of Medicine at Mount Sinai and Perelman School of Medicine at the University of Pennsylvania. The study found that the transthyretin or TTR V122I genetic variant was significantly associated with heart failure and that heredity transthyretin amyloid cardiomyopathy (hATTR-CM) caused by this variant was confirmed at appreciable frequency in individuals of African or Latino ancestry. The results were published in JAMA.

New Discovery in C. difficile Biology Could Lead to Treatments for Dangerous Bacterial Infections
November 25, 2019 - A process called sporulation that helps the dangerous bacterium Clostridium difficile (C. difficile) to survive inhospitable conditions and spread is regulated by epigenetics, factors that affect gene expression beyond the DNA genetic code, researchers at the Icahn School of Medicine at Mount Sinai report. This is the first discovery that epigenetics regulate sporulation in any bacteria. Their research, published November 25th in Nature Microbiology, opens a new window to developing treatments for this devestating infection.

Mount Sinai Researchers Uncover New Molecular Drivers of Parkinson’s Disease
November 20, 2019 - Scientists at the Icahn School of Medicine at Mount Sinai have uncovered new molecular drivers of Parkinson’s disease using a sophisticated statistical technique called multiscale gene network analysis (MGNA). The team was also able to determine how these molecular drivers impact the functions of genes involved in the disease. The results were published in Nature Communications.

Integrated, Multi-"omic" studies of Asthma could lead to precision treatment 
July 2, 2019 - Carefully designed, integrated multi-"omic" studies could accelerate the use of precision medicine for asthma patients, according to researchers from the Icahn School of Medicine at Mount Sinai.  

Study Findings Highlight The Need For Genetic Diversity in Genomic Research
June 19, 2019 - More than three-quarters of genomic data is derived from people of European descent, leaving other ethnic groups understudied. As described in a paper published today in Nature, this collaborative study revealed nearly 1,500 associations between genes and disease in minority populations, serving as a prime example of what racially inclusive research can bring.

Mount Sinai Study Reveals New Genetic Link to Heart Disease
June 18, 2019 - A collaboration involving the Icahn School of Medicine at Mount Sinai, the German Heart Center Munich, AstraZeneca, and Karolinska Institutet in Sweden has demonstrated that more than 30 percent of heart disease risk stems from genetic factors. The study findings, published in the Journal of the American College of Cardiology, introduce the biology of gene networks as a means to better understand the heritability and genetic underpinnings of heart disease.

Individuals Who Attempt Suicide Carry an Increased Genetic Liability for Depression, Regardless of Genetic Disorder. 
June 5, 2019 - More than 90% of people who attempt suicide have a psychiatric diagnosis; however, twin and family studies suggest that the genetic etiology of suicide attempt is partially distinct from that of the psychiatric disorders themselves. 

Mount Sinai Researchers Identify 20 Novel Gene Associations With Bipolar Disorder
May 1, 2019 - In the largest study of its kind, involving more than 50,000 subjects in 14 countries, researchers at the Icahn School of Medicine at Mount Sinai and more than 200 collaborating institutions have identified 20 new genetic associations with one of the most prevalent and elusive mental illnesses of our time—bipolar disorder.

Mount Sinai and Hasso Plattner Launch New Institute for Digital Health 
March 29, 2019 - The Mount Sinai Health System (MSHS) and the Hasso Plattner Institute (HPI) today announced an affiliation that brings together industry leaders with combined expertise in health care delivery, health sciences, biomedical and digital engineering, machine learning and artificial intelligence.

Mount Sinai Researchers Identify More Than 400 Genes Associated With Schizophernia Development 
March 25, 2019 - In the largest study of its kind, involving more than 100,000 people, researchers at the Icahn School of Medicine at Mount Sinai have applied a novel machine learning method to identify 413 genetic associations with schizophrenia across 13 brain regions. 

Mount Sinai Researchers Call for More Diversity in the Next Generation of Personalized Medicine
March 21, 2019 - In a perspective published today in the journal Cell researchers from the Icahn School of Medicine at Mount Sinai reveal that genomic data extracted from population biobanks across the globe contain much less ethnic diversity than desirable.  

Mount Sinai and IBM Researchers Uncover Key to Greater Efficacy in Cancer Treatment
March 21, 2019 - Researchers from Mount Sinai and IBM have discovered a novel clue in explaining how cancer cells with identical genomes can respond differently to the same therapy.

Mount Sinai and USC Researchers Develop Prostate Cancer Prediction Tool That Has Unmatched Accuracy
February 7, 2019 - A team of researchers from the Icahn School of Medicine at Mount Sinai and Keck School of Medicine at the University of Southern California (USC) have developed a novel machine-learning framework that distinguishes between low- and high-risk prostate cancer.

Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases  
January 18, 2019 - The Icahn School of Medicine at Mount Sinai has entered into two exclusive licenses to develop the drug pentosan polysulfate sodium for the treatment of mucopolysaccharidosis (MPS), with Australia-based company Paradigm Biopharmaceuticals Ltd. (ASX: PAR) and ReqMed Company, Ltd. of Japan. 

Researchers Discover That Kidney Disease Gene Affects More Populations Than Previously Thought
December 27, 2018 - In the largest population genomics investigation to date, a team of researchers at the Icahn School of Medicine at Mount Sinai, Stanford University, and the University of Colorado have discovered that kidney disease risk variants of the gene APOL1, previously known to affect African and African American populations, are also found at appreciable frequencies in Caribbean and Latin American populations. 

Mount Sinai Researchers Use "Blacklist" Computing Concept as Novel Method to Streamline Genetic Analysis
December 24, 2018 - Researchers at the Icahn School of Medicine at Mount Sinai and The Rockefeller University have discovered a new use for a long-standing computational concept known as “blacklisting."

Sanofi, Sema4, Mount Sinai Collaborate on Largest Asthma Study of Its Kind
December 4, 2018 - Sema4, a patient-centered predictive health company, and the Mount Sinai Health System today announced the launch of a five-year collaborative study with Sanofi designed to provide new insights into the biological mechanisms and other factors implicated in asthma.

World's First Cannabis Chromosome Map Reveals the Plant's Evolutionary History
December 3, 2018 - Tetrahydrocannabinol (THC) and cannabidiol (CBD), bioactive substances produced by cannabis and sought by medical patients and recreational users, were created thanks to ancient colonization of the plant’s genome by viruses, which researchers at the Icahn School of Medicine at Mount Sinai and the University of Toronto report that they have identified for the first time. 

Icahn School of Medicine Recognized as Certified Mitochondrial Medicine Center
October 29, 2018 - The Icahn School of Medicine has been recognized as a certified Mitochondrial Medicine Center by the Mitochondrial Care Network for the work carried out in the Mitochondrial Medicine Program in the Division of Medical Genetics.  

Mount Sinai Awarded $7.6 Million by the NIH to Study Peanut Allergies
September 25, 2018 - When patients are diagnosed with peanut allergy, they often ask two questions: “How much peanut can I eat before I get sick, and how severe will the reaction be?” says Scott Sicherer, MD, Director, Elliot and Roslyn Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai. 

The Icahn Institute for Genomics and Multiscale Biology Partners in $6.5 Million NIH Award to Advance Precision Medicine and Bioengineering
August 1, 2018 - The National Institutes of Health (NIH) have awarded $6.5 million to a multi-institution consortium for the creation of a biomedical technology resource center that will accelerate the development of predictive models of biological systems to guide precision medicine and bioengineering and provide much-needed model building resources to the research community.

Researchers at Mount Sinai and Sema4 Develop Powerful New Method for Microbiome Analysis
December 11, 2017 - Scientists from the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutionstoday published a report detailing new, more accurate method for identifying individual microbial species and strains in a community.

Mount Sinai Scientists Researchers Identify Six Genes Driving Peanut Allergy Reactions
December 5, 2017 - Mount Sinai researchers have identified six genes that activate hundreds of other genes in children experiencing severe allergic reactions to peanuts.

Scientists Led by Mount Sinai and Sema4 Identify Biomarker for Progression and Drug Response in Brain Cancer
October 16, 2017 - Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions reported results today from a glioblastoma study in which they validated a biomarker indicative of a patient’s prognosis and likely response to specific therapies.

Rare Benign Tumors Hold the "Genetic Recipe" to Combat Diabetes
September 28, 2017 - Mount Sinai researchers discover that insulinomas contain novel molecular pathways and reveal the map to regenerate insulin-producing cells. 

Scientists Construct First Predictive Model of Inflammatory Bowel Disease
September 11, 2017 - Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions today published results that provide new insights in the biologic networks involved in IBD with potential to identify new targets and eventually novel interventions for the treatment of patients living with IBD.

Mount Sinai Researchers Receive $13 Million NIH Grant to Study Impact of Genome Sequencing on Children's Health Outcomes and Health Care Costs 
August 8, 2017 - Researchers at the Icahn School of Medicine at Mount Sinai have been awarded $13 million from the National Institutes of Health (NIH) for a four-year research program, the NYCKidSeq study, that aims to evaluate how genome sequencing can improve health care management by studying the ability to diagnose and treat three main areas of childhood disease. 

Mount Sinai Scientists Find DNA Folding Patterns May Be Related to Neurological Disorders
July 3, 2017 - New study used 3D genome mapping to analyze folding shape changes in neurons. 

Introducing Sema4: A Spinout Company of the Mount Sinai Health System
June 1, 2017 - The Mount Sinai Health System today announced that it has spun out several genetic testing and data sciences components from its Department of Genetics and Genomic Sciences and the Icahn Institute for Genomics and Multiscale Biology into a for-profit company, Sema4. 

Team of Scientists Demonstrate Path for Tackling Rare Cancers with No Effective Treatment
March 23, 2017 - An international team of scientists led by the Icahn School of Medicine at Mount Sinai and UConn School of Medicine have reported the results of a genome sequencing study for an extremely rare form of cancer.  

Berkeley Lights, Inc. and Mount Sinai Expand Relationship 
February 2, 2017 - As part of an expanded collaboration with Berkeley Lights, Inc., the Icahn Institute is purchasing the Beacon platform, the next generation of BLI technology. 

Endometrial Cancer Mutations Detected in Uterine Lavage Samples
December 26, 2016 - In a new study published by John Martignetti and colleagues at the Icahn School of Medicine at Mount Sinai, mutations that have been linked to endometrial cancer can be identified in the uterine lavage fluid.

Helix Announces New Partnerships with National Geographic and Mount Sinai 
October 26, 2016 - The Icahn School of Medicine at Mount Sinai and Helix have partnered to continue to pioneer novel approaches to responsibly engaging consumers in the digital health arena. 

Systems Biology Research Study Reveals Benefits of Vacation and Meditation
August 30, 2016 - Scientists from the Icahn School of Medicine at Mount Sinai, the University of California, San Francisco, and Harvard Medical School used a rigorous study design to assess the biological impact of meditation compared to vacation.

Mount Sinai Research Collaboration Identifies Genes Responsible for Risk of Developing Heart Attack, Stroke, and Related Cardiometabolic Diseases
August 18, 2016 - A profound new level of complexity and interaction among genes has been identified within specific tissues responsible for mediating the inherited risk for cardiometabolic diseases.

Mount Sinai Researchers Report Clinical Utility of Personalized Medicine Program for Cancer Patients
June 1, 2016 - Scientists from the Icahn School of Medicine at Mount Sinai developed and tested a personalized cancer therapy program using an integrated genomic approach that led to therapeutic recommendations for 91 percent of patients.

Researchers from Mount Sinai and Sage Bionetworks Report Analysis of Nearly 600,000 Genomes for Resilience Project
April 11, 2016 - As part of a global collaboration, scientists conducted the largest genome study to date and reported the first systematic search across hundreds of Mendelian disorders in hundreds of thousands of individuals apparently not afflicted with any of these disorders to identify those carrying disease protective factors.

Mount Sinai Researchers Assess Accuracy of Commercially Available Lab Tests
March 28, 2016 - Scientists from the Icahn School of Medicine at Mount Sinai performed an in-depth comparison of basic blood tests run by commercial laboratories and found several cases where inaccurate results would have led to incorrect medical decisions. 

Apple Announces Advancements to ResearchKit 
March 21, 2016 - The Mount Sinai Asthma Health app, designed to track symptom patterns in an individual and identify potential triggers for these symptoms, will use genetic data from 23andMe customers to help researchers better understand ways to personalize asthma treatment. 

23andMe Enables Genetic Research for ResearchKit Apps
March 21, 2016 - The Mount Sinai Asthma Health will be one of the first to implement the module, enabling more than 1.2 million 23andMe customers to upload their genetic information directly through the apps, following an informed consent process. 

Mount Sinai and LifeMap Solutions Expand Asthma Health ResearchKit Study to UK and Ireland 
February 23, 2016 - The Icahn School of Medicine at Mount Sinai and LifeMap Solutions, a company developing innovative digital health solutions, today announced international expansion of the free Asthma Health App to the United Kingdom and Ireland. 

 Mount Sinai Scientists Take Novel Approach to Restore the Microbiome of C-section Newborns in an Effort to Foster Improved Health

February 1, 2016 - Scientists from the Icahn Institute for Genomics and Multiscale Biology in collaboration with NYU Langone Medical Center and a multi-center team of researchers demonstrated for the first time that the microbiome of newborn babies delivered via cesarean section can be partially restored.

Mount Sinai Genetic Testing Laboratory Launches New Carrier Screening Product Line
January 5, 2016 - The Icahn School of Medicine at Mount Sinai announced the launch of a range new carrier screening tests, NextStep Carrier Screening, which are market leading in terms of breadth and depth of coverage. 

Berkeley Lights and the Icahn Institute at Mount Sinai Announce Single Cell Annotation and Genomics Collaboration Program as First BioFoundry Partner
December 10, 2015 - The Icahn Institute is the first BioFoundry™ lab partner implementing Berkeley Lights' OptoSelect™ Light Technology.

New Computational Tools Developed by Mount Sinai Scientists Yield Superior Genome Analysis Results
December 1, 2015 - New data analysis software could help genomics researchers identify genetic drivers of disease with greater efficiency and accuracy.

Mount Sinai Scientists Deploy Novel Data Analysis Method to Identify Subtypes of Common Disease
October 28, 2015 - A new publication from scientists at the Icahn School of Medicine at Mount Sinai offers a glimpse of precision medicine in action.

Mount Sinai and LifeMap Solutions Announce Initial Results for Asthma Health App and New Features to Enhance Clinical Impact
September 29, 2015 - Initial Results from the new Asthma Health App, which remotely recruited and enrolled over 8,600 research participants, demonstrate why mobile apps are fundamentally transforming medical research. 

Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 
June 29, 2015 - A new strategy for uncovering difficult-to-detect, complex forms of genomic variation associated with human disease

Gift to Icahn School of Medicine at Mount Sinai Establishes Harris Center for Precision Wellness 
June 25, 2015 - Center Will Develop Innovative Approaches to Health Monitoring and Wellness Management

Mount Sinai Scientists Develop New Technique for Analyzing the Epigenetics of Bacteria, a Potential New Tool to Combat Pathogens and Overcome Antibiotic Resistance
June 15, 2015 - New methods hold the promise of a new tool to offset the growing challenge of antibiotic resistance by bacterial pathogens

Mount Sinai Scientists Shed Light on the Motivations of Healthy People Seeking Personal Genome Sequencing 
June 8, 2015 - Research will help inform the transition of healthcare to “precision medicine”, where individuals and physicians will routinely obtain and apply genomic information

Mount Sinai Scientists Find Unprecedented Microbial Diversity in Isolated Amazonian Tribe 
April 17, 2015 - Scientists from the Icahn School of Medicine have discovered the most diverse collection of bacteria yet in humans among an isolated tribe of Yanomami Amerindians in the remote Amazonian jungles of Venezuela.

Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 
March 30, 2015 - A key protein previously implicated in Lou Gehrig’s disease and other neurological diseases plays an important role in the response to viral infection.

Icahn School of Medicine at Mount Sinai and LifeMap Solutions Launch Asthma Study for iPhone 
March 9, 2015 - The Icahn School of Medicine at Mount Sinai and LifeMap Solutions, a subsidiary of BioTime (BTX), today announced the launch of a large-scale medical research study that uses the new ResearchKit framework developed by Apple to make it easy for individuals who suffer from Asthma to participate in studies right from their iPhone.

Mount Sinai Scientists Gain New Insight into Hepatitis C Antiviral Resistance 
November 18, 2014 - Nature Communications paper offers pivotal new information about how the virus interacts with and evades therapeutics, as well as new clues to its role in cancer development

The Icahn Institute at Mount Sinai Selects Ion Torrent Sequencing Technology to Drive Discovery in State-of-the-Art Genomics Research Center 
September 11, 2014 - Scientists to sequence hundreds of thousands of DNA samples on the Ion Proton System

Mount Sinai Scientists and International Team Shed New Light on Schizophrenia in Largest Genomic Study Published to Date 
July 22, 2014 - Genes and pathways identified could inform new approaches to treatment and address acute need for drug development for this disorder

Preventing Heart Disease in New York City Children and their Caregivers 
July 15, 2014 - Mount Sinai Heart has been awarded nearly $4 million from the American Heart Association to increase cardiovascular health in NYC children at highest risk.

Mount Sinai and Genetic Disease Foundation Celebrate “Food For Life” Program to Help Kids Manage Inherited Metabolic Diseases

Mount Sinai Genetic Testing Laboratory Nearly Doubles Diseases Covered by Ashkenazi Jewish Carrier Screening Panel 
May 8, 2014 - With expanded screening test, 50 percent of Ashkenazi Jewish individuals are expected to be identified as carriers of at least one of the 38 diseases.

Mount Sinai Scientists Identify First Gene Linked to Heart Muscle Disease in Children 
April 28, 2014 - Findings show several FDA-approved drugs may also be effective in patients diagnosed with dilated cardiomyopathy.

Scientists Reveal New Findings for Reversing Early and Late Atherosclerosis 
February 28, 2014 - Icahn School of Medicine at Mount Sinai study suggests early-stage atherosclerosis is reversible, and identifies new genetic targets for fighting advanced atherosclerosis.

Fast Company Names Icahn School of Medicine as One of World's Top Ten Most Innovative Companies in Big Data 
February 11, 2014 - Ranked in Big Data Sector for "embracing data scientists and supercomputers to build the hospital of the future"

Mount Sinai Genetic Testing Laboratory Launches More Accurate Carrier Screening Test for Spinal Muscular Atrophy 
February 11, 2014 - Use of genetic variants improves detection of SMA carriers in clinical test that will be broadly licensed to testing labs worldwide.

With Large-Scale New Studies, Mount Sinai Scientists Help Underscore the Genetic Complexity in Schizophrenia 
January 22, 2014 - Largest exome studies of schizophrenia to date establish critical new scientific resources for biomedical community and the possibility of more tailored treatment for patients.

Mount Sinai Researchers Identify Molecular Changes in the Brain that May Increase Risk for Multiple Sclerosis 
November 25, 2013 - First genome-wide study in brain tissue from MS patients.

Mount Sinai Researcher Shares 2013 American Society of Human Genetics Leadership Award With Research Partner Wife 
November 4, 2013 - Kurt Hirschhorn, MD, and Rochelle Hirschhorn, MD, receive Victor McKusick Leadership Award.

Berg and Icahn School of Medicine at Mount Sinai Announce R and D Partnership 
October 10, 2013 - Innovative Big Data Approach to Focus on Biological Network Models for Cancer, Central Nervous System and Endocrine Disorders.

Genetic Analysis of Individuals with Autism Finds Gene Deletions 
October 3, 2013 - Deletions may be linked to miswiring of brain neurons.

NIH Grant to support Mount Sinai Research Program to Create Biological Network Model of Alzheimer's Disease in partnership with New York Stem Cell Foundation 
September 18, 2013 - Team to apply innovative analytical methods to gain new insights and identify potential therapies

Mount Sinai Grants Exclusive License to Plexcera Therapeutics to Develop Treatments for Farber Disease and Cystic Fibrosis 
September 10, 2013 - Plexcera was founded by Edward H. Schuchman, MPh, PhD, Professor Professor of Genetics and Genomic Sciences at the Icahn School of Medicine.

Icahn School of Medicine at Mount Sinai Joins Drug-Induced Liver Injury Network 
September 10, 2013 - Mount Sinai has joined the Drug-Induced Liver Injury Network of the NIH to better undrestand drug-induced liver injury, which affects one million people each year.

Mount Sinai Researchers Publish New Edition of Psychiatry "Bible" 
August 7, 2013 - In light of the accelerated pace of discovery in understanding psychiatric illnesses, experts from Mount Sinai have published the 4th edition of Neurobiology of Mental Illness.

Two Mount Sinai Researchers Named “Inventors of the Year” by the New York Intellectual Property Law Association 
June 28, 2013 - The awards were given at the NYIPLA Annual Meeting Awards Dinner last month at the Princeton Club in New York.

The Mount Sinai Medical Center Will Participate in the Aspen Ideas Festival 
June 24, 2013 - Kenneth Davis, MD, President and CEO of The Mount Sinai Medical Center, to speak on the future of medicine at the Aspen Ideas Festival in Colorado

Researchers Identify First Drug Targets in Childhood Genetic Tumor Disorder 
May 23, 2013 - Two mutations central to the development of infantile myofibromatosis may provide new therapeutic targets.

Icahn School of Medicine at Mount Sinai and Bene Pharmachem Gmbh To Collaborate On Clinical Studies For Mucopolysaccharidoses 
May 15, 2013 - The company, based in Germany, is the sole producer of pharmaceutical pentosan polysulfate.

Mount Sinai Researchers Identify Gene Mutations in Congenital Heart Disease 
May 12, 2013 - Using high-throughput sequencing, an international research team including Mount Sinai discovers causes of severe congenital heart disease

Scientists at Mount Sinai Discover a Key Mechanism for the Most Common Form of Alzheimer's Disease 
April 25, 2013 - Research identifies potential therapeutic targets for Late Onset Alzheimer's Disease (LOAD) by revealing a network of genes involved in the inflammatory response.

"Minerva" Super Computer Ushers New Era Of Precision Medicine At Mount Sinai 
April 17, 2013 - Sophisticated algorithms analyze data to develop predictive models of disease in order to better diagnose and treat patients

Mount Sinai Genetic Testing Laboratory Partners with Counsyl to Expand Screening for Genetic Diseases 
January 8, 2013 - Genetic screening testsfor more than 100 disorders are available with on-site counseling.

Scientists Discover New Genetic Basis for Dystonia, a Debilitating Movement Disorder Impacting 500,000 North Americans 
December 18, 2012 - Discovery of new gene provides opportunity for development of new drugs and prenatal screening for dystonia.

Alessia Baccarini, PhD, receives the Paola Campese Award from the Italian Scientists and Scholars Foundation 
December 10, 2012 - The award acknowledges young Italian investigators working in North America, whose research is innovative and impactful.

Common Cranial Birth Defect: Mount Sinai Researchers Validate Genetic Links 
November 19, 2012 - Craniosynostosis is one of the ten most common birth defects, occurring in about 1 out of every 2,500 live births.

Changes in Nerve Cells Caused by Social Isolation May Contribute to the Development of Mental Illness 
November 11, 2012 - Reduced production of myelin, a type of nerve fiber that is lost in diseases like MS, may also play a role in the development of mental illness.

Mount Sinai School of Medicine Offers First-Ever Course with Whole Genome Sequencing 
October 8, 2012 - The course provides opportunity for students to sequence, analyze and interpret their own personal genome using cutting-edge techniques.

Mount Sinai Researchers Solve Mystery Surrounding the Death of Two Sisters Nearly 50 Years Ago 
August 29, 2012 - The study appears in the online edition of The American Journal of Human Genetics.

New Molecular Entity Discovered for Congenital Facial Paralysis 
July 26, 2012 - Ethylin Wang Jabs, MD, and her team have identified a new molecular entity associated with the disorder.

CBS This Morning - "Fetal Genetic Code Mapped: What it Means for You" 
June 8, 2012 - Researchers say, for the first time, they've mapped the genetic code of a fetus.

The New Biology Film Receives Masters Series Award From CINE 
May 29, 2012 - Executive Producer and Creative Director Eric Schadt, PhD, was at the French Embassy in Washington D.C. May 9th to receive the award.

Protein Inhibitor Points To Potential Medical Treatments For Skull And Skin Birth Defects 
May 15, 2012 - Mount Sinai researchers have found new clues in the pathogenesis of skull and skin birth defects associated with a rare genetic disorder.

Scientists Identify FLT3 Gene as a Valid Therapeutic Target in Acute Myeloid Leukemia 
April 15, 2012 - Use of new gene-sequencing technology rapidly identifies mutations that lead to drug resistance

New "Genetic Bar Code" Technique Establishes Ability to Derive DNA Information From RNA 
April 8, 2012 - Discovery May Create Dialogue about DNA and RNA Data Bank Privacy Issues

Mutations in Three Genes Linked to Autism Spectrum Disorders 
April 4, 2012 - Mount Sinai's findings, as part of a trio of papers revealing new genetic targets in autism, are published in the April 4th online issue of the journal Nature.

FierceBiotech IT - " Eric Schadt - Fierce's Top 10 Biotech Techies"

Researchers Discover Five Genetic Markers of Crohns Disease in Jews of European Descent 
March 8, 2012 - Jews of Eastern European descent are 4 times more likely to have Crohn's disease. Mount Sinai researchers have learned why.

Researchers Identify Gene Variants That Cause Stent Thrombosis in People with Coronary Artery Disease 
October 26, 2011 - Identifying these gene variants may allow researchers to prevent a deadly complication of coronary stent implantation in people with coronary artery disease.

Eric Schadt, PhD, Named Director of Institute for Genomics and Multiscale Biology at The Mount Sinai Medical Center 
September 26, 2011 - Dr. Schadt's goal is to create a world-class genomic data center that will help develop and improve the diagnosis and treatment of patients.

NY Times - "The New Generation of Microbe Hunters"

NY Daily News - "Testing Your Baby For Metabolic Disorders"

Mount Sinai School of Medicine and Pacific Biosciences Partner to Advance Clinical Research through Institute for Genomics and Multiscale Biology 
May 16, 2011 - Institute to be directed by PacBio CSO Dr. Eric Schadt; Will Include Single Molecule Real Time Biology User Facility

Mount Sinai’s Ethylin Wang Jabs, MD, Elected as a Member of the Association of American Physicians 
April 18, 2011 - Dr. Jabs was among 64 individuals elected this year and honored at the Association of American Physicians annual meeting.

Chef Floyd Cardoz to Compete on Top Chef Masters on Behalf of Mount Sinai School of Medicine 
April 6, 2011 - Chef Floyd Cardoz will compete on "Top Chef Masters" for the Young Scientist Cancer Research Fund at Mount Sinai.

Consortium of Researchers Identify Four New Genes Linked to Alzheimer’s Disease Risk 
April 3, 2011 - A consortium of researchers has identified four new genes that when present increase the risk of a person developing Alzheimer’s disease later in life.

Dr. AnaLisa DiFeo Recognized As Liz Tilberis Scholar for Ovarian Cancer Research 
December 1, 2010 - AnaLisa DiFeo honored with the Liz Tilberis Grant from the Ovarian Cancer Research Fund to support her research on chemoresistance in ovarian cancer.

Bruce D. Gelb, MD, of Mount Sinai School of Medicine, Elected to the Institute of Medicine 
October 11, 2010 - Dr. Bruce Gelb was among 65 new members and five foreign associates announced today at the IOM’s 40th annual meeting.

Gene Mutations Identified As Cause of Primary Torsion Dystonia 
February 3, 2009 - Mount Sinai researchers have identified mutations in gene THAP1 as a cause of primary torsion dystonia. The discovery may lead to new treatments for this debilitating disease.